(Q36097503)

12 August 2017

Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer (English)

1 reference

12 August 2017

1 reference

1 reference

3

Melissa E Hughes

1 reference

12 August 2017

Michael J Hassett

1

1 reference

12 August 2017

Samuel M Silver

2

1 reference

12 August 2017

Douglas W Blayney

4

1 reference

12 August 2017

Stephen B Edge

5

1 reference

12 August 2017

James G Herman

6

1 reference

12 August 2017

Clifford A Hudis

7

1 reference

12 August 2017

P Kelly Marcom

8

1 reference

12 August 2017

Jane E Pettinga

9

1 reference

12 August 2017

David Share

10

1 reference

12 August 2017

Richard Theriault

11

1 reference

12 August 2017

Yu-Ning Wong

12

1 reference

12 August 2017

Jonathan L Vandergrift

13

1 reference

12 August 2017

Joyce C Niland

14

1 reference

12 August 2017

Jane C Weeks

15

1 reference

12 August 2017

language of work or name

English

0 references

publication date

14 May 2012

1 reference

Journal of Clinical Oncology

12 August 2017

1 reference

12 August 2017

30

1 reference

12 August 2017

18

1 reference

12 August 2017

2218-2226

1 reference

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancers

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

2 October 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Clinical relevance of microsatellite instability in colorectal cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Screening for epidermal growth factor receptor mutations in lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

The MINDACT trial: the first prospective clinical validation of a genomic tool

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

The Human Genome Project: Lessons from Large-Scale Biology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Gene-expression profiles predict survival of patients with lung adenocarcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

NCCN Internet-based data system for the conduct of outcomes research

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Can comorbidity be measured by questionnaire rather than medical record review?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Gene expression profiling and breast cancer care: what are the potential benefits and policy implications?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Gene expression profiles predict survival and progression of pleural mesothelioma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Emergence of Sentinel Node Biopsy in Breast Cancer as Standard-of-Care in Academic Comprehensive Cancer Centers

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397718

TAILORx: trial assigning individualized options for treatment (Rx)

23 September 2018

1 reference

12 December 2020

Ready or not: personal tumor profiling tests take off

1 reference

12 December 2020

Invasive Breast Cancer

1 reference

12 December 2020

The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort

1 reference

12 December 2020

The JNC-7 guidelines and the optimal target for systolic blood pressure

1 reference

12 December 2020

Outcomes assessment in the NCCN

1 reference

12 December 2020

Time trends in systemic adjuvant treatment for node-negative breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2011.38.5740

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

22585699

1 reference